Zurex Pharma
Pioneering the future of healthcare with innovative antimicrobial products to prevent infections.
Pioneering the future of healthcare with innovative antimicrobial products to prevent infections.
Zurex Pharma is a Middleton, Wisconsin based startup established in 2010. The company is dedicated to pioneering the future of healthcare with innovative antimicrobial products aimed at preventing healthcare-acquired infections, particularly focusing on surgical site wounds and catheter-related infections. Zurex Pharma has developed an innovative antimicrobial technology platform to support their mission. Their last venture round secured an investment of $3.78M on 28 December 2023. Biopharma and Health Care are the primary industries Zurex Pharma operates within. Although information about the specific investors or headquarters is not available, the company's dedication to revolutionizing healthcare through advanced antimicrobial solutions showcases a promising venture for potential investors in the healthcare and biopharma sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $3.78M | - | 28 Dec 2023 | |
| Venture Round | $7.50M | - | 04 Jun 2020 | |
| Series D | $9.00M | 3 |
|
12 Jun 2018 |
| Series C | $6.24M | - | 11 Aug 2016 | |
| Series B | $4.10M | 3 |
|
02 Jul 2014 |
No recent news or press coverage available for Zurex Pharma.
We care about your data, and we'd love to use cookies make your experience better.
